Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024, at 2:00 p.m. ET in Miami, FL.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn, Instagram, and X.

Investor Contact Ashley Kaplowitz 786-252-1419 ashley.kaplowitz@sagerx.com

Media Contact Matthew Henson 917-930-7147 matthew.henson@sagerx.com

Grafico Azioni Sage Therapeutics (NASDAQ:SAGE)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Sage Therapeutics
Grafico Azioni Sage Therapeutics (NASDAQ:SAGE)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Sage Therapeutics